- Every manufacturing sub-sector is open to foreign investors at 100% ownership in 2026, after the 2024 list removed the last two restrictions.
2026年制造业所有细分领域均向外开开放、可100%持股，2024年版清单删除了最后两项限制。- The 2024 revision deleted the publication-printing Chinese-control rule and the traditional-Chinese-medicine secret-formula production ban.
2024年修订删除了出版物印刷须中方控股的规定，以及中成药保密处方产品生产禁令。- With “access” solved, Beijing’s policy focus has shifted to “operating permission” — closing the “big door open, small door closed” gap.
“准入”问题解决后，政策重心转向”准营”——消除”大门开、小门不开”的落差。- Foreign manufacturing investment remains substantial: the sector drew 86.97 billion yuan of actual FDI in the first five months of 2026.
制造业外资仍可观：2026年前5个月制造业实际使用外资869.7亿元。- High-tech manufacturing is the growth engine, with electronic and communications equipment FDI up 18.2% and computer/office-equipment FDI up 29.7% year-on-year in early 2026.
高技术制造业是增长引擎，2026年初电子及通信设备制造外资增18.2%、计算机及办公设备制造增29.7%。- Post-access hurdles — product registration, standards, GMP, licensing — now matter more than equity caps for manufacturers.
准入后壁垒——产品注册、标准、GMP、许可——对制造商而言已比股比上限更重要。- The 2025 Encouraged Catalogue (1,679 entries) steers foreign manufacturers toward advanced and green manufacturing with incentives.
2025年版鼓励目录（1,679条）以激励引导外资制造商投向先进与绿色制造。
China’s 2026 Manufacturing Liberalization: Full Market Access for Foreign Investors | 中国2026年制造业全面放开：外资准入全面解禁
From Restricted to Fully Open
Manufacturing is the field where China’s foreign-investment opening is most complete. Over little more than a decade, the negative list moved from capping foreign equity across wide swaths of industry to removing every manufacturing restriction. The decisive step came with the *Special Administrative Measures for Foreign Investment Access (Negative List) (2024 Edition)* (NDRC & MOFCOM Order No. 23, effective 1 November 2024), which cut the national list to 29 items and deleted the final two manufacturing limitations. As NDRC officials stated in March 2026, “manufacturing access restrictions have been fully zeroed out.” For a foreign manufacturer, the question of whether it may own 100% of a Chinese plant is, in principle, settled: the answer is yes, across automobiles, semiconductors, pharmaceuticals, food, chemicals, and machinery alike.
What the 2024 List Actually Removed
The two manufacturing items deleted in 2024 were specific but symbolic:
- Publication printing. The long-standing requirement that publication printing be controlled by the Chinese party was removed, ending a restriction that had sat on the list since the early reform era.
- Traditional Chinese medicine. A prohibition on the application of certain TCM processing techniques (steaming, stir-frying, calcining, roasting) and on the production of pharmaceuticals based on confidential formulae was lifted.
Their removal brought the national list from 31 to 29 items and, more importantly, emptied the manufacturing column entirely. Earlier tranches had already opened automaking — the phased removal of the 50% passenger-vehicle joint-venture cap was completed at the end of 2022 — and had relaxed limits on rail equipment, mining, and shipbuilding. By 2026, no manufacturing sub-sector carries a mandated Chinese partner or foreign-equity ceiling.
The “Big Door Open, Small Door Closed” Problem
Opening the access door, however, is not the same as being able to operate. Chinese officials now openly describe a “big door open, small door closed” (大门开、小门不开) problem: the equity barrier is gone, but operating permissions — licences, product registrations, technical standards, and certification — can still delay or block a foreign manufacturer from actually selling. MOFCOM and NDRC have made clear that the 2026 priority is to move from 准入 (access) to 准营 (operating permission), ensuring that once a manufacturer is admitted it can genuinely do business. This reframing matters for advisors: the diligence that once centred on equity structure must now centre on the permitting and certification pathway.
The 2026 Investment Picture
The data show manufacturing remains a major destination for foreign capital even after full liberalisation. According to MOFCOM, in the first five months of 2026 China recorded 25,297 newly established foreign-invested enterprises (up 5.3% year-on-year) and actual utilised foreign capital of 327.29 billion yuan. Of that, manufacturing absorbed 86.97 billion yuan. The structure is shifting toward higher value:
| Indicator (Jan–May 2026) | Value / change |
|---|---|
| New FIEs established | 25,297 (+5.3% yoy) |
| Actual utilised FDI (total) | 327.29 billion yuan (−8.6% yoy) |
| Manufacturing actual FDI | 86.97 billion yuan |
| High-tech industry actual FDI | 130.14 billion yuan (+19.4% yoy, 39.8% of total) |
| Electronic & communications equipment mfg FDI | +18.2% yoy |
| Computer & office equipment mfg FDI | +29.7% yoy |
| R&D and design services FDI | +96.2% yoy |
The high-tech share — nearly 40% of all utilised FDI — and the double-digit growth in advanced manufacturing confirm that liberalisation is channeling foreign money into exactly the segments Beijing wants to deepen.
Where the Growth Is: High-Tech Manufacturing
The strongest momentum is in technology-intensive manufacturing. Electronic and communications equipment manufacturing drew 18.2% more foreign capital year-on-year in early 2026, and computer and office equipment manufacturing grew 29.7%. These are precisely the sectors where the encouraged catalogue (see below) offers the richest incentives and where China’s complete supply chains give foreign investors a reason to localise rather than export. Semiconductors, new-energy vehicles, high-end medical devices, and advanced materials all sit in this zone — fully open on the negative list and actively courted through the encouraged catalogue and local investment-promotion packages.
Operating Permission, Not Access, Is the New Bottleneck
For a manufacturer entering China in 2026, the binding constraints are almost never equity. They are:
- Product registration. Drugs and medical devices must be registered with the National Medical Products Administration (NMPA); food and cosmetics face similar registration or filing.
- Standards and certification. China Compulsory Certification (CCC) and a widening set of national and industry standards apply; conformity assessment can be lengthy.
- Environmental and safety permitting. Manufacturing sites need environmental-impact approvals and safety production licences.
- Data and cross-border flows. Where a plant’s operations touch important data, the cross-border data rules introduced in recent years add a compliance layer.
A market-entry plan should map each of these early, because they — not the negative list — determine time-to-market.
Practical Guidance for Manufacturers
- Assume 100% ownership is available. Structure as a WFOE unless non-manufacturing ancillary activities pull you into a restricted sector.
- Screen ancillary services. A manufacturing WFOE that also wants to distribute, do R&D, or run a testing lab should check whether those add-on activities hit the services restrictions still on the list.
- Check the encouraged catalogue. The 2025 edition (effective 1 February 2026, 1,679 entries) lists advanced and green manufacturing for tariff, land, and tax incentives — confirm your product lines qualify.
- Build the permitting timeline first. Model NMPA/CCC/environmental approvals before committing a launch date.
- Use the FTZ pre-check. Inside an FTZ, the access pre-check system surfaces hidden licence needs early.
- Plan localisation. With supply chains complete and incentives available, a localised footprint often beats an import-only model.
Manufacturing is, in 2026, the easiest manufacturing-sector entry China has ever offered a foreign investor — provided the entrant plans for operating permission, not just ownership.
中国2026年制造业全面放开：外资准入全面解禁
从受限到全面开放
制造业是中国外资开放最彻底的领域。在十余年间，负面清单从对工业广泛领域设股比上限，走向取消每一项制造业限制。决定性一步来自《外商投资准入特别管理措施（负面清单）（2024年版）》（国家发展改革委、商务部第23号令，2024年11月1日施行），它将全国版清单减至29条，删除最后两项制造业限制。正如国家发展改革委2026年3月所言，”制造业领域外资准入限制全面清零”。对外国制造商而言，能否100%持有中国工厂的问题原则上已解决：汽车、半导体、医药、食品、化工、机械皆然。
2024年版究竟删除了什么
2024年删除的两项制造业条目虽具体却具象征意义：
- 出版物印刷。 长期存在的”出版物印刷须由中方控股”要求被取消，结束了自改革初期即列于清单的限制。
- 中药。 禁止投资中药饮片蒸、炒、炙、煅等炮制技术应用及中成药保密处方产品生产的禁令被解除。
两项删除使全国版由31条降至29条，更重要的是将制造业栏目彻底清空。此前的批次已开放汽车制造——乘用车合资股比50%上限的渐进取消于2022年底完成——并放宽了轨道交通设备、采矿、船舶制造的限制。至2026年，无任何制造业细分领域强制要求中国伙伴或设外资股比上限。
“大门开、小门不开”问题
然而，打开准入之门不等于能够经营。中国官员现公然描述”大门开、小门不开”问题：股权壁垒已去，但经营许可证、产品注册、技术标准与认证仍可能拖延或阻止外国制造商实际销售。商务部与国家发展改革委已明确，2026年重心是从”准入”转向”准营”，确保制造商准入后真正能开展业务。这一重构对顾问至关重要：曾经围绕股权结构的尽职调查，如今须围绕许可与认证路径展开。
2026年投资图景
数据显示，全面放开后制造业仍是外资重要目的地。据商务部，2026年前5个月全国新设外商投资企业25,297家（同比+5.3%），实际使用外资3,272.9亿元；其中制造业吸收869.7亿元。结构向高价值迁移：
| 指标（2026年1—5月） | 数值／变化 |
|---|---|
| 新设外资企业 | 25,297家（同比+5.3%） |
| 实际使用外资（合计） | 3,272.9亿元（同比−8.6%） |
| 制造业实际使用外资 | 869.7亿元 |
| 高技术产业实际使用外资 | 1,301.4亿元（同比+19.4%，占总额39.8%） |
| 电子及通信设备制造外资 | 同比+18.2% |
| 计算机及办公设备制造外资 | 同比+29.7% |
| 研发与设计服务外资 | 同比+96.2% |
高技术占比接近四成，先进制造业双位数增长，印证开放正将外资引入北京希望深化的细分领域。
增长所在：高技术制造业
最强动能来自技术密集型制造。2026年初电子及通信设备制造外资同比增18.2%，计算机及办公设备制造增29.7%。这些正是鼓励目录（见下）激励最丰、且中国完整供应链令外资倾向本地化而非出口的领域。半导体、新能源汽车、高端医疗器械、先进材料均处此区——负面清单上完全开放，又通过鼓励目录与地方招商包积极争取。
准营而非准入成为新瓶颈
对2026年进入中国的制造商，约束几乎从不是股权，而是：
- 产品注册。 药品与医疗器械须向国家药品监督管理局（NMPA）注册；食品、化妆品亦有注册或备案。
- 标准与认证。 中国强制性产品认证（CCC）及日益增多的国标、行标适用；符合性评估可能漫长。
- 环保与安全许可。 制造场所需环评批复与安全生产许可证。
- 数据与跨境流动。 运营触及重要数据时，近年出台的数据跨境规则新增合规层。
市场准入计划应尽早梳理上述每一项，因为它们——而非负面清单——决定上市时间。
给制造商的实操指引
- 默认可100%持股。 除非非制造附属活动将你拉入受限行业，否则设为外商独资企业。
- 筛查附属服务。 制造型 WFOE 若兼营分销、研发或检测实验室，须查这些附加活动是否触及清单上仍受限的服务业。
- 核对鼓励目录。 2025年版（2026年2月1日施行，1,679条）列明先进与绿色制造，享关税、用地、税收优惠——确认你的产品线符合。
- 先建许可时间表。 在锁定上市日期前，先建模 NMPA／CCC／环评审批。
- 利用自贸区预检。 区内准入预检系统可尽早暴露隐性许可需求。
- 规划本地化。 供应链完整且激励可用，本地化布局往往优于纯进口模式。
2026年，制造业是历史上中国向外开投资者提供的最易进入的制造领域——前提是进入者规划的是”准营”，而不仅是”持股”。
Sources